The onset of chronic obstructive pulmonary disease (COPD) is heterogeneous, and current
approaches to define distinct disease phenotypes are lacking. In addition to clinical …

Chronic obstructive pulmonary disease (COPD) is a syndrome that comprises several lung
pathologies, but subphenotyping the various disease subtypes has been difficult. One …

Chronic obstructive pulmonary disease (COPD) is the leading cause of respiratory mortality
worldwide. Genetic risk loci provide new insights into disease pathogenesis. We performed …

Genome-wide association studies (GWAS) have identified more than 20 genomic regions
associated with chronic obstructive pulmonary disease (COPD) susceptibility. However, the …

Chronic obstructive pulmonary disease (COPD) is a heterogeneous group of chronic lung
conditions. Genome-wide association studies have identified single-nucleotide …

There is an unmet need for blood biomarkers in diagnosis and prognosis of chronic
obstructive pulmonary disease (COPD). The search for these biomarkers has been …

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity
and mortality throughout the world and is mainly characterized by persistent airflow …

Chronic obstructive pulmonary disease (COPD) poses a major risk for public health, yet
remarkably little is known about its detailed pathophysiology. Definition of COPD as …

Chronic obstructive pulmonary disease (COPD) is a common and progressive disease that
is influenced by both genetic and environmental factors. For many years, knowledge of the …

Chronic obstructive pulmonary disease (COPD) is a clinically heterogeneous disease
composed of variable degrees of airflow obstruction, emphysematous destruction, and small …